Duchesnay Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Duchesnay Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10896
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Duchesnay Inc (Duchesnay) is a pharmaceutical company that offers medications for use in pregnancy. The company’s products include diclectin, an antinauseant drug used for the management of nausea and vomiting; pregvit, a supplement that allow attaining nutrient levels of folic acid, iron, and calcium; and proctofoam-HC, a mucoadhesive analgesic and anti-inflammatory foam for the relief of anorectal inflammation and swelling. It also provides ladysystem, a feminine therapy to treat urinary stress incontinence caused by pelvic floor weakening; and mictoryl indicated for symptomatic treatment of urinary incontinence or increased urinary frequency and urgency in patients with overactive bladder. The company markets pharmaceutical products and medical devices in a variety of therapeutic areas, including obstetrics and gynecology, proctology, urology, and bacterial vaginosis. Duchesnay is headquartered in Blainville, Quebec, Canada.

Duchesnay Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Duchesnay Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Duchesnay Enters Into Distribution Agreement With Tzamal Medical For Diclectin Drug 10
Licensing Agreements 11
Duchesnay Receives Rights for Osphena from Shionogi 11
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 12
Duchesnay Inc – Key Competitors 13
Duchesnay Inc – Key Employees 14
Duchesnay Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Product News 16
07/06/2018: Alliance Pharma Marketing Authorisation for Diclectin in the UK 16
06/25/2018: Actress, Mom and Singer Jana Kramer is Expecting and Again Partnering with Duchesnay USA to Spread the Word about Bonjesta (doxylamine succinate – pyridoxine hydrochloride) 17
04/02/2018: Duchesnay USA Announces Availability of Bonjesta (doxylamine succinate – pyridoxine hydrochloride) in the United States 18
Product Approvals 19
Jun 07, 2018: Alliance Pharma Announces Positive Opinion for Diclectin 19
Jul 28, 2017: Alliance Pharma announce Update on Diclectin 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Duchesnay Inc, Pharmaceuticals & Healthcare, Key Facts 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Duchesnay Enters Into Distribution Agreement With Tzamal Medical For Diclectin Drug 10
Duchesnay Receives Rights for Osphena from Shionogi 11
Alliance Pharma Enters into Licensing Agreement with Duchesnay for Diclectin 12
Duchesnay Inc, Key Competitors 13
Duchesnay Inc, Key Employees 14
Duchesnay Inc, Subsidiaries 15

List of Figures
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Duchesnay Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Duchesnay Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • New Standard Energy Ltd (NSE):石油・ガス:M&Aディール及び事業提携情報
    Summary New Standard Energy Ltd (NSE), formerly Hawk Resources Ltd, is an oil and gas exploration and production company. The company carries out acquisition, exploration, and develops oil and gas; and hydrocarbon properties. It holds interest in production and development project in the Eagle Ford …
  • PT Pembangkitan Jawa-Bali-エネルギー分野:企業M&A・提携分析
    Summary PT Pembangkitan Jawa-Bali (PJB), a subsidiary of PT PLN (Persero), generates and supplies electricity. It is responsible to meet the electricity requirements of the Java-Madura-Bali (JAMALI) electric system. The company generates electricity from energy sources such as oil, natural gas, coal …
  • Deutsche Telekom AG (DTE):企業の財務・戦略的SWOT分析
    Deutsche Telekom AG (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Maines Paper and Foodservice, Inc.:企業の戦略・SWOT・財務分析
    SummaryMaines Paper and Foodservice, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …
  • BEA Systems, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' BEA Systems, Inc. Mergers and A …
  • Dawnrays Pharmaceutical (Holdings) Limited (2348):企業概要、財務及び戦略的SWOT分析
    Summary Dawnrays Pharmaceutical (Holdings) Limited (Dawnrays) is a pharmaceutical company. The company develops, manufactures and markets cephalosporin antibiotics and specific medicines to healthcare markets. Its products include cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium …
  • AmeriGas Partners, L.P.:企業の戦略・SWOT・財務分析
    AmeriGas Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary AmeriGas Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Shinto Paint CO., Ltd. (4615):企業の財務及び戦略的SWOT分析
    Summary Shinto Paint CO., Ltd. (Shinto) is a chemical manufacturing company that manufactures chemical and paint products. It manufactures, processes and sells products such as paints, pigments, synthetic fats, oils, chemicals, electronic equipment, optical communication equipment, magnetic equipmen …
  • Koronis Pharma, Inc.(製薬・医療分野):企業M&A動向
    Summary Koronis Pharma, Inc. (Koronis) is a biotechnology company. The company develops antiviral therapeutics based on Viral Decay Acceleration mechanism. It develops KP-1461 for AIDS/human immunodeficiency virus; and products for the treatment of hepatitis C and RSV. Its Viral Decay Acceleration t …
  • VGX International, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' VGX International, Inc. Mergers …
  • Debenhams Plc:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Debenhams Plc Mergers and Acqui …
  • Pearson plc:企業の戦略・SWOT・財務分析
    SummaryPearson plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings - …
  • Havells India Ltd (HAVELLS):企業の財務・戦略的SWOT分析
    Havells India Ltd (HAVELLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • 3W Power S.A. (3W9K):企業のM&A・提携動向(発電分野)
    Summary 3W Power S.A. (3W Power) is a provider of power electronic solutions and related services. It offers wide range of products which includes rectifiers and chargers, industrial UPS and inverters, control modules, Switch mode power supply, solar invertors and smart grid energy storage. The comp …
  • James Fisher and Sons plc (FSJ):企業概要、財務及び戦略的SWOT分析
    Summary James Fisher and Sons plc (James Fisher) is an energy service provider. The company provides service to marine and oil and gas industries. It offers services such as diving and ROV, inspection and monitoring, lifting and handling, marine services, mooring and fendering, nuclear facilities an …
  • Cynvenio Biosystems Inc:企業のM&A・提携動向(医療機器分野)
    Summary Cynvenio Biosystems Inc (Cynvenio) is a cancer diagnostic company that develops and commercializes rare cell isolation technologies. The company offers products such as LiquidBiopsy consumables, that automates the isolation of rare cells from whole blood; LiquidBiopsy platform; and Everest s …
  • Venere Net S.p.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Venere Net S.p.A. Mergers and A …
  • Hydra Biosciences, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Hydra Biosciences, Inc. Mergers …
  • Hals-Development:企業の戦略・SWOT・財務分析
    SummaryHals-Development - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • HL Global Enterprises Limited:企業の戦略・SWOT・財務分析
    SummaryHL Global Enterprises Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compan …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆